Preliminary Phytochemical Screening of Bark Extracts of Ficus- glomerata (Gular), a lactiferous deciduous tree from Indian origin

Authors

  • Sonali Sharma M.Pharm (Pharmacology), Saraswati Higher Education and Technical College of Pharmacy, Varanasi, Uttar Pradesh, India.
  • Abhishek Kumar Principal, Saraswati Higher Education and Technical College of Pharmacy, Varanasi, Uttar Pradesh, India.
  • Prashant Singh Assistant Professor, Saraswati Higher Education and Technical College of Pharmacy, Varanasi, Uttar Pradesh, India.
  • Karishma Pathak M Pharm (Pharmacology), Saraswati Higher Education and Technical College of Pharmacy, Varanasi, Uttar Pradesh, India.
  • Rajeev Shukla Director, Saraswati Higher Education and Technical College of Pharmacy, Varanasi, Uttar Pradesh, India.

Keywords:

Phytochemical Screening, Ficus-glomerata, Secondary metabolite, Ethanol, Hydroalcohol and Soxhlation Extraction

Abstract

Medicinal plants have been used as traditional treatments for various kinds of human diseases for thousands of years. Ficus glomerata is an evergreen moderate to large sized spreading lactiferous, deciduous tree 15-18m high found in throughout the warmer part of Asia, Africa, America and Australia. It is often cultivated round villages in India for its edible fruit. The aim of the current study was to screen the various phytoconstituents from three different solvents viz ethanol, hydroalcohol and aqueous extracts of bark of Ficus glomerata. By using standard procedure these three different solvents extracts were subjected for
qualitative phytochemical screening. It was found that bark extracts of this plant contains various secondary metabolites such as alkaloids, tannins, flavonoids, saponins, carbohydrates, triterpenoids and steroids. Resulting data from phytochemical testing of three different extracts of bark of Ficus glomerata may be serve as a tool for the quality control of drug in future prospect, for the cure of diverse disease conditions.

How to cite this article: Sharma S, Kumar A, Singh P et al. Preliminary Phytochemical Screening of Bark Extracts of Ficus glomerata (Gular), a Lactiferous Deciduous Tree from Indian Origin. J Durg Dis Dev 2021; 5(1): 17-21.

DOI: https://doi.org/10.24321/2581.6861.202103

References

Ganatra SH, Durge SP, Patil SU. Preliminary phytochemicals investigation and TLC analysis of Ficus racemosa leaves. Journal of Chemical and Pharmaceutical Research 2012; 4(5): 2380-4.

Sudhakar A, Asrar Sheriff M, Sultan Mohideen AK, et al. Phytochemical Screening of Ficus glomerata. Roxb. Galled leaves. International Journal of Pharmaceutical & Biological Archives 2012; 3(1): 105-7.

Kannahi M, Vinotha K. Antimicrobial activity of lawsonia inermis leaf extracts against some human pathogens. International Journal of Current Microbiology and Applied Sciences 2013; 2(5): 342-9.

Joy PP, Thomas J, Mathew S, et al. Medicinal plants. tropical horticulture. Naya Prokash. 2001; 2: 449-632.

Ahmed F, Urooj A. Traditional uses, medicinal properties and pharmacology of Ficus racemosa: A review. 2010.

Ghani A. Medicinal plants of Bangladesh: chemical constituents and uses. Asiatic Society of Bangladesh. 1st edition. 1998.

Satyavati GV, Raina MK, Sharma M. Medicinal plants of India. Indian Council of Medical Research, New Delhi. 1976.

Bhandary SK, Kumari NS, Bhatt VS, et al. Preliminary phytochemical screening of various extracts of Punica-granatum peel, whole fruit and seeds. Nitte University Journal of Health Science, 2012.

Augusti KT, Cherian S. Insulin sparing action of leucopelar gonidine derivative isolated from Ficus bengalensis Linn. Indian Journal of Experimental Biology 2008; 33: 608-11.

Mandal SC, Maity TK, Das J et al. Antibacterial activity on Ficus racemosa Linn. Leaf extract. Journal of Ehthnopharmacology 2000; 72(1&2): 87-92.

Downloads

Published

2022-02-24

How to Cite

Sharma, S., Kumar, A., Singh, P., Pathak, K., & Shukla, R. (2022). Preliminary Phytochemical Screening of Bark Extracts of Ficus- glomerata (Gular), a lactiferous deciduous tree from Indian origin. Journal of Drug Discovery and Development ( ISSN:2581-6861), 5(1), 17-21. Retrieved from https://medicaljournalshouse.com/index.php/JDrug-Discovery-Development/article/view/637

Issue

Vol. 5 No. 1 (2021): Journal of Drug Discovery and Development

Section

Research Article

License

Copyright (c) 2021 Journal of Drug Discovery and Development ( ISSN:2581-6861)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

We, the undersigned, give an undertaking to the following effect with regard to our article entitled
“_______________________________________________________________________________________________________________________________________________________________________________
________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-

1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.

2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.

3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.

4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.

5. I/We also agree to the authorship of the article in the following sequence:-

Authors' Names (in sequence) Signature of Authors
1. _____________________________________ _____________________________________
2. _____________________________________ _____________________________________
3. _____________________________________ _____________________________________
4. _____________________________________ _____________________________________
5. _____________________________________ _____________________________________
6. _____________________________________ _____________________________________
7. _____________________________________ _____________________________________
8. _____________________________________ _____________________________________

Important

(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.

(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.

(iii). If the authorship is contested at any stage, the article will be either returned or will not be
processed for publication till the issue is solved.